Clinical Trial Update: Single Center Study of Apremilast for the Treatment of Hidradenitis Suppurativa [Phase 2]

View source ↗

Summary

A single-center Phase 2 trial evaluating apremilast for hidradenitis suppurativa has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hidradenitis Suppurativa

Drugs mentioned

• Apremilast (apremilast)

Snippet

Sponsor: Florida Academic Dermatology Centers | Conditions: Hidradenitis Suppurativa | Phase 2 | Status: COMPLETED